RHB Retail Research
Trading Stocks - Duopharma Biotech
Duopharma Biotech’s buying momentum may have returned after it recovered above the 21-day SMA line lately. Last Friday’s candle sent the stock to its 1-month high, thereby enhancing the bullish sentiment. An upbeat bias may emerge above the MYR1.39 level, with an exit set below the MYR1.35 mark. Towards the upside, the immediate resistance is at the MYR1.53 level, followed by the MYR1.60 threshold.
Source: RHB Securities Research - 13 Apr 2020
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Duopharma Biotech - Lacking Near-Term Re-Rating Catalysts; D/G NEUTRAL
Created by rhboskres | Aug 26, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
2
4
save malaysia!
Visa-free travel to China extended for Malaysians to 30 days
5
6
7
Good Articles to Share
8
Good Articles to Share
Iran to hold nuclear talks with three European powers in Geneva on Friday, Kyodo reports
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
